[1] 中华人民共和国国家卫生和计划生育委员会.GBZ 130-2013医用X射线诊断放射防护要求[S].北京:中国标准出版社,2013. [2] 中华人民共和国卫生部.GBZ/T 201.2-2011放射治疗机房的辐射屏蔽规范第2部分电子直线加速器放射治疗机房[S].北京:中国标准出版社,2011. [3] 中华人民共和国国家卫生和计划生育委员会.GBZ/T 201.3-2014放射治疗机房的辐射屏蔽规范第3部分γ射线源放射治疗机房[S]. 北京:中国标准出版社,2014. [4] 中华人民共和国国家卫生和计划生育委员会.WS 533-2017临床核医学患者防护要求[S].北京:中国标准出版社,2017. [5] Hwon HW,Kim JP,Lee HJ,et al.Radiation Dose from Whole-Body F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography:Nationwide Survey in Korea[J]. Journal of Korean Medical Science,2016 Feb;31(Suppl 1):s69-s74. [6] The design of diagnostic medcial facilities where ionizing radiation is used[R].The Radiological Protection Institute of Ireland,2009. [7] Ray McGinnis.Rad Pro Calculator Version 3.26,2009. [8] Smith DS,Stabin MG.Exposure rate constants and lead shielding values for over 1100 radionuclides[J].Health Physics,2012,102(3):271-91. [9] Delacroix D,Guerre JP,Leblanc P,et al.Radionuclide and radiation protection data handbook 2nd edition(2002)[J].Radiation Protection dosimetry,2002,98(1):9-168. [10] ICRP, 1987. Protection of the Patient in Nuclear Medicine (and Statement from the 1987 Como Meeting of ICRP)[R]. ICRP Publication 52. Ann. ICRP 17(4). [11] AAPM,2006.American Association of Physicists in Medicine,AAPM Task Group 108:PET and PET/CT Shielding Requiremenst[R].Med Phys,33,1,2006. [12] ICRP, 2004. Release of Patients after Therapy with Unsealed Radionuclides[R]. ICRP Publication 94. Ann. ICRP 34(2). [13] Release of Patients After Radionuclide Therapy[R].IAEA,2009.
